Page History

...

Group 1 is a control group of 20 subjects, 10 male and 10 female, which are to be dosed with vehicle once per day for 14 days, given a 7-day rest period, dosed again with vehicle once per day for 14 days, given a second 7-day rest period, and dosed with vehicle once per day for the final 14 days.
Group 2 is a group of 20 subjects, 10 male and 10 female, which are to be dosed at 50 mg/kg of product/intervention article once per day for 14 days, given a 7-day rest period, dosed at 800 mg/kg once per day for 14 days, given a second 7-day rest period, and dosed at 400 mg/kg of product once per day for the final 14 days.
Group 3 is a group of 20 subjects, 10 male and 10 female, which are to be dosed at 400 mg/kg of product/intervention article once per day for 14 days, given a 7-day rest period, dosed at 50 mg/kg of product once per day for 14 days, given a second 7-day rest period, and dosed at 800 mg/kg of product once per day for the final 14 days.
Group 4 is a group of 20 subjects, 10 male and 10 female, which are to be dosed at 800 mg/kg of product/intervention article once per day for 14 days, given a 7-day rest period, dosed at 400 mg/kg of product once per day for 14 days, given a second 7-day rest period, and dosed at 50 mg/kg of product once per day for the final 14 days.

...

This example shows the start and end rules and durations for the different product exposure elements, indicating whether they follow a product an exposure or nonexposure element.

Dataset wrap

Name	te

Jira

showSummary	false
server	Issue Tracker (JIRA)
serverId	85506ce4-3cb3-3d91-85ee-f633aaaf4a45
key	TOBA-216

Dataset2

Row	STUDYID	DOMAIN	ETCD	ELEMENT	TESTRL	TEENRL	TEDUR
1	TDM5	TE	SCRN	Screen	Start of Preexposure	10 days after start of Element	P10D
2	TDM5	TE	CONTROL	Vehicle Control	First dosing with vehicle control following a nonexposure Element	14 days after start of Element	P14D
3	TDM5	TE	REST	Rest for 7 days	1 day after last dose in a product an exposure Element	7 days after start of Element	P7D
4	TDM5	TE	50A	50 mg/kg Drug A, once daily	First dosing with 50 mg/kg Drug a following a nonexposure Element	14 days after start of Element	P14D
5	TDM5	TE	400A	400 mg/kg Drug A, once daily	First dosing with 400 mg/kg Drug a following a nonexposure Element	14 days after start of Element	P14D
6	TDM5	TE	800A	800 mg/kg Drug A, once daily	First dosing with 800 mg/kg Drug a following a nonexposure Element	14 days after start of Element	P14D

...

In this example, there are 4 trial sets. The experimental factors considered are type of exposure (vehicle control or intervention articleproduct) and sequencing of exposure levels. The applicant is providing the arm code, applicant-defined group code, group label, control type, dose level and units, and planned number of subjects (total) only.

Dataset wrap

Name	tx

Dataset2

Concentration of Intervention ArticleConcentration Unit for Intervention Article

Row	STUDYID	DOMAIN	SETCD	SET	TXSEQ	TXPARMCD	TXPARM	TXVAL
1	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	1	ARMCD	Arm Code	1
2	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	2	SPGRPCD	Applicant-Defined Group Code	1
3	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	3	GRPLBL	Group Label	Group 1, Control
4	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	4	TCNTRL	Control Type	VEHICLE CONTROL
5	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	5	ITVCONC	TRTDOS	Dose Level	0
6	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	6	ITVCONCU	TRTDOSU	Dose Units	mg/kg/day
7	TDM5	TX	1	Group 1, (Vehicle Control Name) once daily for each of 3 dosing periods of 14 days each with 7-day rests between	7	SPLANSUB	Planned Number of Subjects	20
8	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	8	ARMCD	Arm Code	2
9	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	9	SPGRPCD	Applicant-Defined Group Code	2
10	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	10	GRPLBL	Group Label	Group 2, 50-800-400 mg/kg/day
11	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	11	ITVCONC	Concentration of Intervention Article	SEE PROTOCOL
12	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	12	ITVCONCU	Concentration Unit for Intervention Article	SEE PROTOCOL
13	TDM5	TX	2	Group 2, (Intervention Name) once daily dosing in sequence: 50-800-400 mg/kg (14 days each) with 7-day rests between	13	SPLANSUB	Planned Number of Subjects	20
14	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	14	ARMCD	Arm Code	3
15	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	15	SPGRPCD	Applicant-Defined Group Code	3
16	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	16	GRPLBL	Group Label	Group 3, 400-50-800 mg/kg/day
17	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	17	ITVCONC	Concentration of Intervention Article	SEE PROTOCOL
18	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	18	ITVCONCU	Concentration Unit for Intervention Article	SEE PROTOCOL
19	TDM5	TX	3	Group 3, (Intervention Name) once daily dosing in sequence: 400-50-800 mg/kg (14 days each) with 7-day rests between	19	SPLANSUB	Planned Number of Subjects	20
20	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	20	ARMCD	Arm Code	4
21	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	21	SPGRPCD	Applicant-Defined Group Code	4
22	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	22	GRPLBL	Group Label	Group 4, 800-400-50 mg/kg/day
23	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	23	ITVCONC	Concentration of Intervention Article	SEE PROTOCOL
24	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	24	ITVCONCU	Concentration Unit for Intervention Article	SEE PROTOCOL
25	TDM5	TX	4	Group 4, (Intervention Name) once daily dosing in sequence: 800-400-50 mg/kg (14 days each) with 7-day rests between	25	SPLANSUB	Planned Number of Subjects	20

Page tree

Versions Compared

Old Version 11

New Version Current

Key